Zhou F, Zhou C. Chemotherapy Should Be Combined With Checkpoint Inhibitors in the Treatment of
Patients With Stage IV EGFR-Mutant NSCLC Whose Disease Has Progressed on All
Available Tyrosine Kinase Inhibitors. J Thorac Oncol 2021;16:1622-1626.
PMID: 34561035